PodParley PodParley
GPH 67: Diabetes

EPISODE · Mar 28, 2026 · 47 MIN

GPH 67: Diabetes

from Clinical Deep Dives · host Dr Manaan Kar Ray

Diabetes has emerged as one of the most significant non-communicable diseases worldwide, with rapidly increasing prevalence across high-, middle-, and low-income countries. Once considered a condition of affluence, it now disproportionately affects disadvantaged populations.This episode examines:• Global epidemiology of type 1 and type 2 diabetes• Pathophysiology of insulin deficiency and insulin resistance• The metabolic syndrome and clustering of risk• Obesity, diet, and physical inactivity• Urbanisation and nutritional transition• Early-life programming and intergenerational risk• Complications - cardiovascular disease, nephropathy, neuropathy, retinopathy• Health system burden and long-term management• Prevention through population-level interventionsType 2 diabetes represents the intersection of biology and environment. Genetic susceptibility interacts with calorie-dense diets, reduced physical activity, and social determinants of health. The result is a chronic condition that demands sustained health system engagement.The episode explores the life-course trajectory of metabolic risk and the importance of prevention strategies that operate beyond individual clinical care - including food systems, urban planning, and fiscal policy.Diabetes is not merely a disorder of glucose regulation. It is a marker of structural change.────────────────────────────Key Takeaways• Diabetes prevalence is increasing globally• Type 2 diabetes is strongly linked to modifiable environmental factors• Early detection reduces long-term complications• Prevention requires structural and policy interventions• Complications drive substantial morbidity and health expenditure• Intergenerational risk transmission is increasingly recognised• Equity considerations are central to effective diabetes control This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 67: Diabetes

0:00 47:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!